Macquarie Group »

Inhibrx Biosciences shares owned by Macquarie Group

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Macquarie Group from 13F filings

Historical chart of Macquarie Group investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Macquarie Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $379k 4.0k 94.75

More positions owned by Macquarie Group

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Cisco Systems (CSCO)
Lam Research Corp Com New (LRCX)
Exxon Mobil Corporation (XOM)
Tesla Motors (TSLA)

View all positions for Macquarie Group

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Morgan Stanley
Sanofi
Viking Global Investors
HighTower Advisors
Bank of America Corporation
BlackRock
Schonfeld Strategic Advisors
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Woodline Partners
Capital Research Global Investors
Partner Fund Management
Sofinnova Ventures

View all funds holding Inhibrx Biosciences